| Style | Citing Format |
|---|---|
| MLA | Qorbani M, et al.. "Socioeconomic Inequalities and Trends in the Prevalence of Childhood Obesity Phenotypes in Iran From 2000 to 2030." Journal of Diabetes and Metabolic Disorders, vol. 25, no. 2, 2026, pp. -. |
| APA | Qorbani M, Sheidaei A, Baygi F, Mahdavi Gorabi A, Heshmat R, Heidari Beni M, Mazaheri Tehrani S, Kelishadi R (2026). Socioeconomic Inequalities and Trends in the Prevalence of Childhood Obesity Phenotypes in Iran From 2000 to 2030. Journal of Diabetes and Metabolic Disorders, 25(2), -. |
| Chicago | Qorbani M, Sheidaei A, Baygi F, Mahdavi Gorabi A, Heshmat R, Heidari Beni M, Mazaheri Tehrani S, Kelishadi R. "Socioeconomic Inequalities and Trends in the Prevalence of Childhood Obesity Phenotypes in Iran From 2000 to 2030." Journal of Diabetes and Metabolic Disorders 25, no. 2 (2026): -. |
| Harvard | Qorbani M et al. (2026) 'Socioeconomic Inequalities and Trends in the Prevalence of Childhood Obesity Phenotypes in Iran From 2000 to 2030', Journal of Diabetes and Metabolic Disorders, 25(2), pp. -. |
| Vancouver | Qorbani M, Sheidaei A, Baygi F, Mahdavi Gorabi A, Heshmat R, Heidari Beni M, et al.. Socioeconomic Inequalities and Trends in the Prevalence of Childhood Obesity Phenotypes in Iran From 2000 to 2030. Journal of Diabetes and Metabolic Disorders. 2026;25(2):-. |
| BibTex | @article{ author = {Qorbani M and Sheidaei A and Baygi F and Mahdavi Gorabi A and Heshmat R and Heidari Beni M and Mazaheri Tehrani S and Kelishadi R}, title = {Socioeconomic Inequalities and Trends in the Prevalence of Childhood Obesity Phenotypes in Iran From 2000 to 2030}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {25}, number = {2}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Qorbani M AU - Sheidaei A AU - Baygi F AU - Mahdavi Gorabi A AU - Heshmat R AU - Heidari Beni M AU - Mazaheri Tehrani S AU - Kelishadi R TI - Socioeconomic Inequalities and Trends in the Prevalence of Childhood Obesity Phenotypes in Iran From 2000 to 2030 JO - Journal of Diabetes and Metabolic Disorders VL - 25 IS - 2 SP - EP - PY - 2026 ER - |